Abstract: The invention relates to an improved method for the anodic alkoxylation of an organic compound with an alcohol comprising between 1 and 4 C atoms, in particular methanol, in a reactor comprising a membrane electrode assembly (MEA). The invention uses a reactor comprising an MEA that contains a cation exchange membrane or a microporous polypropylene membrane, whereby one or both electrode layers were created using carbon black and/or graphite, optionally doped with a heavy metal and a sulfonated, polyfluorinated polymer or copolymer in a liquid suspension containing a suspension medium.

Abstract: The invention relates to urethane prepolymers, obtainable by reaction of: (A) 15 to 85 wt.-% of one or more ?,?-terminated poly(meth)acrylate diols, (B) 0 to 30 wt.-% of one or more radically curable, polyhydroxy-functional compounds, (C) 14 to 60 wt.-% of one or more polyisocyanates, (D) 1 to 40 wt.-% of a monofunctional compound, reactive vis-à-vis isocyanate groups, which also contains one or more radically curable grouping, as well as their use.

Abstract: The invention relates to polymerizable materials comprising two components, where component I comprises: (a) from 0.1 to 20% by weight of at least one vinyl ether, (b) from 10 to 89.9% by weight of at least one ethylenically unsaturated monomer which is not a vinyl ether, (c) from 0.001 to 5% by weight of at least one accelerator, (d) from 9.999 to 89.899% by weight of fillers, thixotropy assistants, retardants and other auxiliaries, and component II comprises: (e) from 0.1 to 20% by weight of at least one barbituric acid derivative and/or at least one malonylsulfamide which is able to initiate the free-radical polymerization, and (f) from 0 to 89.9% by weight of fillers, thixotropy assistants, retardants and other auxiliaries, (g) from 10 to 80% by weight of conventional plasticizers, and to the use thereof.

Abstract: The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases.

Abstract: Organic substrates, such as cyclic ethers, N-substituted amides, ketones, alkyl-aromatic substances and alkyl-heteroaromatic substances can be anodically alkoxylated, especially methoxylated, in the presence of an alcohol. Alkoxylation in the presence of a mediator or in a divided cell using a solid electrolyte is known. The anodic alkoxylation according to the invention is carried out in the absence of a mediator in an undivided electrolytic cell using a diamond anode or gold anode and allows for high yields and a high current efficiency.

Abstract: The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases

Abstract: The invention relates to compositions containing: (a) 14 to 55 wt.-% fillers, (b) 3 to 35 wt.-% of at least one mono- or polyethylenically unsaturated compound which is not a urethane (meth)acrylate, (c) 0.1 to 5 wt.-% of at least one initiator system which is capable of starting a radical reaction, (d) 1 to 40 wt.-% plasticizers, (e) 0 to 10 wt.-% auxiliaries such as dyes, pigments, stabilizers, solvents, rheological additives such as flow-improvers and/or retarders, and (f) 30 to 81.9 wt.-% of at least two urethane (meth)acrylates with different molecular weights, these being present in a molecular weight ratio of 1.5:1 to 50:1.

Abstract: The invention relates to novel isotope-coded affinity tags for use in mass-spectrometric analysis of proteins. The invention also relates to the production and use of these novel tags.

Abstract: The present invention relates to compounds of the general formula (I), their preparation and use as pharmaceutical compositions asintegrin antagonists, especially as ?4? and/or ?4?7 ?and/or ?9?1 intergrin antagonists and in particular for the production of pharmaceutical compositions suitable for the inhibition or the prevention of cell adhesion and cell-adhesion mediated disorders. Examples are the treatment and the prophylaxis of atherosclerosis, asthma, chronic obstructive pulmonary disease (COPD), allergies, diabetes, inflammatory bowel disease, multiple sclerosis, myocardial ischemia, rheumatoid arthritis, transplant rejection and other inflammatory, autoimmune and immune disorders.

Abstract: The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases.

Abstract: The present invention relates to compounds of the general formula (I), 1

Abstract: A gas diffusion structure for polymer electrolyte fuel cells having a sheet-like carbon substrate made hydrophobic and having two main opposing surfaces and a contact layer on one of these surfaces. The contact layer is formed of an intimate mixture of at least one hydrophobic polymer, which can be polyethylene, polypropylene or polytetrafluoroethylene, and finely divided carbon particles, wherein the weight percentage of the carbon particles relative to the total weight of the contact layer amounts to 40 to 90 wt. %. The gas diffusion structure is a carbon substrate made hydrophobic by at least one hydrophobic polymer and the hydrophobic polymers are restricted to two layers extending from both opposing surfaces into the carbon substrate down to a depth of from 5 to 40 &mgr;m and the hydrophobic polymers fill of from 20 to 60% of the pore volume within those layers.

Abstract: The present invention relates to a compound of the general formula (I), wherein R1 together with the C atom to which it is attached, and R2 together with the N atom to which it is attached, form a piperidinyl ring; X represents a bond, oxygen or —NR12—; and Y represents oxygen; pharmaceutical compositions containing such a compound, as well as the use of such a compound for the production of pharmaceutical compositions, and for the treatment of inflammatory, auto-immune and immune diseases.

Abstract: Particulate materials are cold molded by preheating a binder and the material to be bound to a temperature of from 160 to 240° C., and then press molding at a temperature less than 80° C. and at a pressure of from 1 to 120 bar to give a molding, wherein the binder contains a polymer powder or aqueous polymer dispersion thereof, the polymer having a glass transition temperature Tg greater than 80° C. and a complex viscosity less than 15,000 Pa·s at 190° C., and derived from one or more comonomer units from the group of vinyl esters of optionally branched C1-18 alkylcarboxylic acids, (meth)acrylic esters of optionally branched C1-15 alcohols, dienes, olefins, vinylaromatics, and vinyl halides. The moldings exhibit excellent properties including resistance to sagging at elevated temperatures, and are recyclable.

Abstract: The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases.

Abstract: The present invention relates to compounds of general formula (I), wherein the residues R represent organic radicals, X represents a bond, oxygen or —NR12 and Y represents oxygen or sulfur, processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory, autoimmune and immune diseases.

Abstract: A process for the electrochemical preparation of hydrogen peroxide, in particular an aqueous hydrogen peroxide solution, by the electrochemical reaction of oxygen and hydrogen in a fuel cell. By increasing the thickness of the membrane layer in a membrane electrode unit (MEU) in the fuel cell, it is possible to substantially increase the concentration of H2O2 in the aqueous hydrogen peroxide solution obtained at the cathode.

Abstract: The invention provides devices for packaging a chip shaped carrier having an active surface which is adapted to be read by an electro-optical reading device, e.g. a surface which carries an array of DNA oligonucleotides. The invention further provides processes for assembling the devices. The invention also provides systems for carrying out evaluations and/or monitoring methods involving electro-optical reading of an activce surface of a chip shaped carrier.

Abstract: The present invention relates to compounds of general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases.

Abstract: The invention relates to polymerizable materials comprising two components, where component I comprises: (a) from 0.1 to 20% by weight of at least one vinyl ether, (b) from 10 to 89.9% by weight of at least one ethylenically unsaturated monomer which is not a vinyl ether, (c) from 0.001 to 5% by weight of at least one accelerator, (d) from 9.999 to 89.899% by weight of fillers, thixotropy assistants, retardants and other auxiliaries, and component II comprises: (e) from 0.1 to 20% by weight of at least one barbituric acid derivative and/or at least one malonylsulfamide which is able to initiate the free-radical polymerization, and (f) from 0 to 89.9% by weight of fillers, thixotropy assistants, retardants and other auxiliaries, (g) from 10 to 80% by weight of conventional plasticizers, and to the use thereof.